Jagan R Muppidi

7PUBLICATIONS
61CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 31, 2026
Phosphorylation Protects Oncogenic RAS from LZTR1-Mediated Degradation.

|Oct 16, 2024
Phosphatidylserine phospholipase A1 enables GPR34-dependent immune cell accumulation in the peritoneal cavity.

Hanson Tam, Ying Xu, Jinping An

|Jul 18, 2024
Gα13 restricts nutrient driven proliferation in mucosal germinal centers.

Hang T Nguyen, Moyi Li, Rahul Vadakath

|Apr 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma.

Sean R Corcoran, James D Phelan, Jaewoo Choi

|May 04, 2023
Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas.

Sebastian Scheich, Jiji Chen, Jiamin Liu

|Jun 27, 2022
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma.

Grace M Pindzola, Raud Razzaghi, Rachel N Tavory

Pageof 2

Frequent Collaborators

4 joint publications

James D Phelan

3 joint publications

Stefania Pittaluga

3 joint publications

Thomas Oellerich

3 joint publications

Ryan M Young